Lista de obras - Craig Gedye - Dominio Público Uruguay

A comprehensive promoter landscape identifies a novel promoter for CD133 in restricted tissues, cancers, and stem cells.

artículo científico publicado en 2013

A new geometry for tetramanganese: fused open cubanes

ANZUP MDT Masterclass Convenor Welcome

artículo científico publicado en 2019

ATIM-16. PHASE 1 STUDY RESULTS OF M7824 (MSB0011359C), A BIFUNCTIONAL FUSION PROTEIN TARGETING TGF- AND PD-L1, AMONG PATIENTS WITH RECURRENT GLIOBLASTOMA (rGBM)

Can Hemp Help? Low-THC Cannabis and Non-THC Cannabinoids for the Treatment of Cancer

scientific article published on 23 April 2020

Canadian guideline on genetic screening for hereditary renal cell cancers

artículo científico publicado en 2013

Cancer stem cells are underestimated by standard experimental methods in clear cell renal cell carcinoma

artículo científico publicado en 2016

Cancer stem cells in urologic cancers.

artículo científico publicado en 2009

Cancer/testis antigens can be immunological targets in clonogenic CD133+ melanoma cells.

artículo científico publicado en 2009

Cell surface profiling using high-throughput flow cytometry: a platform for biomarker discovery and analysis of cellular heterogeneity

artículo científico publicado en 2014

Cell-Free DNA Blood Collection Tubes Are Appropriate for Clinical Proteomics: A Demonstration in Colorectal Cancer.

artículo científico publicado en 2018

Checkpoint immunotherapy for cancer: superior survival, unaccustomed toxicities.

artículo científico publicado en 2015

Current and Evolving Methods to Visualize Biological Data in Cancer Research

artículo científico publicado en 2016

Durable Response of Metastatic Squamous Cell Carcinoma of the Skin to Ipilimumab Immunotherapy.

artículo científico publicado en 2016

ECSA/DPPA2 is an embryo-cancer antigen that is coexpressed with cancer-testis antigens in non-small cell lung cancer

scientific article published on 01 June 2008

Efficient generation of patient-matched malignant and normal primary cell cultures from clear cell renal cell carcinoma patients: clinically relevant models for research and personalized medicine

artículo científico publicado en 2016

Enlisting the willing: A study of healthcare professional-initiated and opt-in biobanking consent reveals improvement opportunities throughout the registration process

artículo científico publicado en 2017

Escherichia coli PII protein: purification, crystallization and oligomeric structure.

artículo científico publicado en 1994

Forsaking cures for cancer: why are we discarding the tumour biospecimens of most patients?

artículo científico publicado en 2016

Human perforin mutations and susceptibility to multiple primary cancers

artículo científico publicado en 2013

Immunotherapy of advanced or metastatic melanoma.

artículo científico publicado en 2007

Isolation and Characterization of Cancer Stem Cells In Vitro ⬇️

artículo científico publicado el 1 de enero de 2013

Management of advanced kidney cancer: Canadian Kidney Cancer Forum 2013 Consensus Update: Canadian Kidney Cancer Forum 2013

artículo científico publicado en 2013

Mycoplasma Infection Alters Cancer Stem Cell Properties in Vitro

artículo científico publicado en 2015

New treatments for metastatic melanoma ⬇️

artículo científico publicado en 2014

Oncolytic targeting of renal cell carcinoma via encephalomyocarditis virus

artículo científico publicado en 2010

Optimising treatment for Australian melanoma patients can save taxpayers millions of dollars annually.

artículo científico publicado en 2015

Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV)

artículo científico publicado en 2018

Patients' experiences and preferences for opt-in models and health professional involvement in biobanking consent: A cross-sectional survey of Australian cancer outpatients.

artículo científico publicado en 2018

Patterns of response to anti-PD-1 treatment: an exploratory comparison of four radiological response criteria and associations with overall survival in metastatic melanoma patients

artículo científico publicado en 2016

Phenotypic heterogeneity and instability of human ovarian tumor-initiating cells ⬇️

artículo científico publicado el 30 de marzo de 2011

Predicting clinical outcome through molecular profiling in stage III melanoma

artículo científico publicado en 2008

Primary Results from SAUL, a Multinational Single-arm Safety Study of Atezolizumab Therapy for Locally Advanced or Metastatic Urothelial or Nonurothelial Carcinoma of the Urinary Tract

scientific article published on 23 March 2019

RBTT-07. NUTMEG: A RANDOMISED PHASE II STUDY OF NIVOLUMAB AND TEMOZOLOMIDE (TMZ) VS TMZ ALONE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM): TRIAL IN PROGRESS

Real-world efficacy, toxicity and clinical management of ipilimumab treatment in metastatic melanoma.

artículo científico publicado en 2015

Research Perspective on Utilizing and Valuing Tumor Biobanks

artículo científico publicado en 2018

Results of a Prospective Phase 2 Pilot Trial of 177Lu–PSMA-617 Therapy for Metastatic Castration-Resistant Prostate Cancer Including Imaging Predictors of Treatment Response and Patterns of Progression

artículo científico publicado en 2019

Stem cell media culture of melanoma results in the induction of a nonrepresentative neural expression profile

artículo científico publicado en 2012

Stem/progenitor cell marker expression in clear cell renal cell carcinoma: a potential relationship with the immune microenvironment to be explored ⬇️

artículo científico publicado en 2020

Superoxide is an antagonist of antiinflammatory drugs that inhibit hypochlorous acid production by myeloperoxidase

artículo científico publicado en 1993

Targeting the TSH receptor in thyroid cancer.

artículo científico publicado en 2017

The Ludwig institute for cancer research Melbourne melanoma cell line panel

artículo científico publicado en 2013

The Precursor for Nerve Growth Factor (proNGF) in Thyroid Cancer Lymph Node Metastases: Correlation with Primary Tumour and Pathological Variables

scientific article published on 25 November 2019

The RANK-RANKL axis: an opportunity for drug repurposing in cancer?

scientific article published on 17 January 2019

The precursor for nerve growth factor (proNGF) is not a serum or biopsy-rinse biomarker for thyroid cancer diagnosis

scientific article published on 27 November 2019

The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells.

artículo científico publicado en 2008

Lista de obras de Craig Gedye

A comprehensive promoter landscape identifies a novel promoter for CD133 in restricted tissues, cancers, and stem cells.

A new geometry for tetramanganese: fused open cubanes

ANZUP MDT Masterclass Convenor Welcome

ATIM-16. PHASE 1 STUDY RESULTS OF M7824 (MSB0011359C), A BIFUNCTIONAL FUSION PROTEIN TARGETING TGF- AND PD-L1, AMONG PATIENTS WITH RECURRENT GLIOBLASTOMA (rGBM)

Can Hemp Help? Low-THC Cannabis and Non-THC Cannabinoids for the Treatment of Cancer

Canadian guideline on genetic screening for hereditary renal cell cancers

Cancer stem cells are underestimated by standard experimental methods in clear cell renal cell carcinoma

Cancer stem cells in urologic cancers.

Cancer/testis antigens can be immunological targets in clonogenic CD133+ melanoma cells.

Cell surface profiling using high-throughput flow cytometry: a platform for biomarker discovery and analysis of cellular heterogeneity

Cell-Free DNA Blood Collection Tubes Are Appropriate for Clinical Proteomics: A Demonstration in Colorectal Cancer.

Checkpoint immunotherapy for cancer: superior survival, unaccustomed toxicities.

Current and Evolving Methods to Visualize Biological Data in Cancer Research

Durable Response of Metastatic Squamous Cell Carcinoma of the Skin to Ipilimumab Immunotherapy.

ECSA/DPPA2 is an embryo-cancer antigen that is coexpressed with cancer-testis antigens in non-small cell lung cancer

Efficient generation of patient-matched malignant and normal primary cell cultures from clear cell renal cell carcinoma patients: clinically relevant models for research and personalized medicine

Enlisting the willing: A study of healthcare professional-initiated and opt-in biobanking consent reveals improvement opportunities throughout the registration process

Escherichia coli PII protein: purification, crystallization and oligomeric structure.

Forsaking cures for cancer: why are we discarding the tumour biospecimens of most patients?

Human perforin mutations and susceptibility to multiple primary cancers

Immunotherapy of advanced or metastatic melanoma.

Isolation and Characterization of Cancer Stem Cells In Vitro ⬇️

Management of advanced kidney cancer: Canadian Kidney Cancer Forum 2013 Consensus Update: Canadian Kidney Cancer Forum 2013

Mycoplasma Infection Alters Cancer Stem Cell Properties in Vitro

New treatments for metastatic melanoma ⬇️

Oncolytic targeting of renal cell carcinoma via encephalomyocarditis virus

Optimising treatment for Australian melanoma patients can save taxpayers millions of dollars annually.

Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV)

Patients' experiences and preferences for opt-in models and health professional involvement in biobanking consent: A cross-sectional survey of Australian cancer outpatients.

Patterns of response to anti-PD-1 treatment: an exploratory comparison of four radiological response criteria and associations with overall survival in metastatic melanoma patients

Phenotypic heterogeneity and instability of human ovarian tumor-initiating cells ⬇️

Predicting clinical outcome through molecular profiling in stage III melanoma

Primary Results from SAUL, a Multinational Single-arm Safety Study of Atezolizumab Therapy for Locally Advanced or Metastatic Urothelial or Nonurothelial Carcinoma of the Urinary Tract

RBTT-07. NUTMEG: A RANDOMISED PHASE II STUDY OF NIVOLUMAB AND TEMOZOLOMIDE (TMZ) VS TMZ ALONE IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM): TRIAL IN PROGRESS

Real-world efficacy, toxicity and clinical management of ipilimumab treatment in metastatic melanoma.

Research Perspective on Utilizing and Valuing Tumor Biobanks

Results of a Prospective Phase 2 Pilot Trial of 177Lu–PSMA-617 Therapy for Metastatic Castration-Resistant Prostate Cancer Including Imaging Predictors of Treatment Response and Patterns of Progression

Stem cell media culture of melanoma results in the induction of a nonrepresentative neural expression profile

Stem/progenitor cell marker expression in clear cell renal cell carcinoma: a potential relationship with the immune microenvironment to be explored ⬇️

Superoxide is an antagonist of antiinflammatory drugs that inhibit hypochlorous acid production by myeloperoxidase

Targeting the TSH receptor in thyroid cancer.

The Ludwig institute for cancer research Melbourne melanoma cell line panel

The Precursor for Nerve Growth Factor (proNGF) in Thyroid Cancer Lymph Node Metastases: Correlation with Primary Tumour and Pathological Variables

The RANK-RANKL axis: an opportunity for drug repurposing in cancer?

The precursor for nerve growth factor (proNGF) is not a serum or biopsy-rinse biomarker for thyroid cancer diagnosis

The regulatory T cell-associated transcription factor FoxP3 is expressed by tumor cells.